tbuckley/cabot-search huggingface dataset:
EP08.02-058 A Case Series of Patients With Kras KRAS G12C Mutation Treated With Sotorasib - Croatian Experience
Authors: F. Seiwerth, L. Bitar, I. Lukić Franolić, A. Šajnić, M. Jakopović, M. Samaržija
Journal: Journal of Thoracic Oncology (2022)
EP08.01-081 A Phase I Dose-Escalation Study of HBM4003, an anti-CTLA-4 Heavy Chain Only Monoclonal Antibody, in Combination with Pembrolizumab
Authors: S. Lu, M. Sun, L. Ding, J. Ji, D. Yang, X. Gan, Y. Zhao, X. Liu, X. Chen
Journal: Journal of Thoracic Oncology (2022)
EP08.01-084 Non-Invasive Detection of Predictive Biomarkers for PD-1 Inhibitor Treated Non-Small Cell Lung Cancer Patients
Authors: S. Stensgaard, A. Thomsen, J.G. Dissing, S.H. Knudsen, P. Meldgaard, B.S. Sørensen
Journal: Journal of Thoracic Oncology (2022)
EP16.02-007 Detection of Clinically Relevant Fusions and Exon Skipping Alterations in Non Small Cell Lung Cancer Patients Liquid Biopsies
Authors: E. Sánchez-Herrero, A. Giménez-Capitán, L. Robado de Lope, R. Serna-Blasco, S. Viteri, S. Sanz-Moreno, C. Mayo-de-Las-Casas, V. Calvo, R. Rosell, V. González-Rumayor, M. Provencio, A. Romero, M.Á. Molina
Journal: Journal of Thoracic Oncology (2022)
EP08.02-150 Molecular Heterogeneity of Compound Epidermal Growth Factor Receptor (EGFR) Mutations in Lung Adenocarcinoma (LAC)
Authors: R. Brooks, A.M. Shiarli, H. Wang, K. ThippuJayaprakash, H. Liu, D. Gilligan, C. Hannon, R. Bulusu
Journal: Journal of Thoracic Oncology (2022)
EP08.02-055 Targeting Lung Adenocarcinoma Cells with a Novel Disulfide Reductase Inhibitor
Authors: F. Johnson, J. Ferrarone, A. Liu, C. Brandstädter, R. Munuganti, D. Farnsworth, D. Lu, J. Luu, T. Sihota, S. Jansen, A. Nagelberg, R. Shi, G. Forcina, X. Zhang, G. Cheng, S. Spencer Miko, G. de Rappard-Yuswack, P. Sorensen, S. Dixon, U. Guha, K. Becker, H. Djaballah, R. Somwar, H. Varmus, G. Morin, W. Lockwood
Journal: Journal of Thoracic Oncology (2022)
EP08.01-101 Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Asian Patients with Advanced NSCLC
Authors: Y. Huang, J.J. Zhao, Y.Y. Soon, A. Kee, S.H. Tay, F. Aminkeng, Y. Ang, A. Wong, B.C. Goh, R. Soo
Journal: Journal of Thoracic Oncology (2022)
EP08.03-004 Outcomes of Oligometastatic Non-Small Cell Lung Cancer Patients Undergoing Surgical Resection: A Single Center Experience
Authors: F. Gorguner, Y. Kahya, G. Kocaman, K.A. Kavak, B.M. Yenigun, C. Yuksel, S. Enon, A. Kayi Cangir
Journal: Journal of Thoracic Oncology (2022)
EP14.05-009 LUMINANCE: A Phase IIIb Study of Durvalumab + Platinum-Etoposide for First-Line Treatment of Extensive-Stage SCLC (ES-SCLC)
Authors: N. Reinmuth, F. DeMarinis, N. Leighl, S. Sadow, K. Davey, M. Özgüroğlu
Journal: Journal of Thoracic Oncology (2022)
EP08.02-089 Toxicity of Sequential Tyrosine Kinase Inhibitors After Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer
Authors: L. Jones, R. Rittberg, B. Leung, A. Shokoohi, A. Pender, S. Wong, Z. Al-Hashami, Y. Wang, C. Ho
Journal: Journal of Thoracic Oncology (2022)
EP08.02-130 Tegavivint Exhibits Antitumor Activity and Modulates Macrophage Phenotype in the Non-small Cell Lung Cancer Tumor Microenvironment
Authors: R. Chandra, J.V. Park, A. Nguyen, L. Girard, M. Peyton, A. Das, K. Avila, B. Gao, S.K. Horrigan, R.A. Brekken, J.D. Minna
Journal: Journal of Thoracic Oncology (2022)
EP08.02-102 Feasibility and Clinical Utility of ctDNA for Detection of Sensitizing and Resistance EGFR Mutations in Patients with Non-small Cell Lung Cancer
Authors: M. Garcia de Herreros, C. Teixido, V. Diez, A. Arcocha, R. Reyes, V. Albarran-Artahona, E. Marin, P. Galvan, D. Martinez, J. Padrosa, L. Vegas, O. Castillo, A. Prat, N. Viñolas, N. Reguart, L. Mezquita
Journal: Journal of Thoracic Oncology (2022)
EP08.02-138 SAFFRON: Ph3 Savolitinib + Osimertinib vs Chemotherapy in EGFRm NSCLC with MET Overexpression/Amplification Post-Osimertinib
Authors: S. Lu, W. Xu, A. Telaranta-Keerie, N. Jia, R. Hartmaier
Journal: Journal of Thoracic Oncology (2022)
EP08.02-022 Investigating Partners in Crime: Osimertinib Resistance Mechanisms in Non-small Cell Lung Cancer Using Focused CRISPR Screen
Authors: B. Uluata Dayanc, S. Eris, E. Cakiroglu, F.A. Mazi, O.S. Coskun, D. Demirci, G. Karakulah, S. Senturk
Journal: Journal of Thoracic Oncology (2022)
EP08.01-083 Real-World PD-(L)1 Inhibitor Treatment Pattern and Outcomes in Advanced Non-Small Cell Lung Cancer in Sweden
Authors: G. Wagenius, A. Vikström, A. Berglund, S. Salomonsson, G. Bencina, X. Hu, D. Chirovsky, H. Brunnström, S. Ekman
Journal: Journal of Thoracic Oncology (2022)
EP11.01-011 Clinical Application of Liquid Biopsy for Assessing Early EGFR Mutation Detection in Non-Small Cell Lung Carcinoma
Authors: A. Rathor, P.S. Malik, P. Tanwar, S. Khurana, S. Kumar, A. Mohan, A. Nambirajan, D. Jain
Journal: Journal of Thoracic Oncology (2022)
EP08.01-095 Efficacy and Safety of Combining Endostar with Camrelizumab plus Chemotherapy in Advanced NSCLC Patients: A Multi-Center Retrospective Study
Authors: L. Wu, X.X. Pu, L.B. Chen, Z.Q. Wang, Y.L. Liu, K. Li, Y. Kong, F. Xu, J. Li, L. Xu, Y. Xu, C.Y. Tang, L.M. Xiao, P. Liu
Journal: Journal of Thoracic Oncology (2022)
EP16.02-002 Circulating Tumor DNA (ctDNA) Changes in Patients With Lung Cancer from a Real-World Prospective Clinico-Genomic (PCG) Study
Authors: A. Chiang, M. Kaur, Z.J. Assaf, A.D. Fine, Y. Zhao, Y. Cao, R. Madison, G.R. Oxnard, K. Tolba, R. Zuniga, S. Lakhanpal, V. Antic, A.B. Bourla, K. Schulze
Journal: Journal of Thoracic Oncology (2022)
EP16.04-020 Dysregulation of 14-3-3 Signaling Adapters in Lung Adenocarcinoma, New Insights Into the Impact on Cancer Cell Biology
Authors: R. Hamon, X. Jiang, J. Toubia, C. Coolen, A. Lopez, P.N. Reynolds, S.M. Pitson, J. Woodcock
Journal: Journal of Thoracic Oncology (2022)
EP08.02-044 Adding Alectinib Rescues Progression on Osimertinib Due to Acquired ALK p.R1275Q Variant in EGFR p.L858R-mutated NSCLC
Authors: E.M. Urbanska, J.B. Sørensen, L.C. Melchior, E. Santoni-Rugiu
Journal: Journal of Thoracic Oncology (2022)
EP10.01-019 Rowing Against Cancer: From a Support Project to a Research Program. Perspectives and Challenges of Rowing in Metastatic Lung Cancer Patients
Authors: T. Franchina, G. Ficarra, D. Fugazzotto, A. Bitto, L. Magaudda, F. Trimarchi, D. Di Mauro, M.A. Zarzana, F. Cacciola, P. Aspria, V. Franchina, V. Adamo
Journal: Journal of Thoracic Oncology (2022)
EP16.02-003 Real World Experience and Feasibility of Tissue Informed CGP and ctDNA Testing in a Cohort of NSCLC Patients
Authors: G. Azzi, M. Krainock, C. Flippen, N. Nagovski, Z.E. Segota, C.C. Palsuledesai, P. Olshan, A. Aleshin
Journal: Journal of Thoracic Oncology (2022)
EP14.01-006 CeLEBrATE: Phase II trial of CarbopLatin, Etoposide, Bevacizumab and Atezolizumab in Patients with exTEnsive-Stage SCLC-GOIRC-01-2019
Authors: E. Andrini, G. Lamberti, F. Mazzoni, F. Riccardi, A. Bonetti, A. Follador, D. Giardina, C. Genova, G. Guaitoli, A. Frassoldati, M. Brighenti, I. Colantonio, G. Pasello, C. Ficorella, S. Cinieri, M. Tiseo, F. Gelsomino, M. Tognetto, K. Rihawi, A. Ardizzoni
Journal: Journal of Thoracic Oncology (2022)
EP08.02-117 Online CME Improves Clinicians’ Ability to Identify and Manage Patients with NSCLC and EGFR Exon 20 Insertion Mutations
Authors: M.A. Worst, A. Small, H. Kadkhoda, K. Reid, M. Cannon, A. Furedy, A. Sarris, S. Hsiao, D.R. Camidge
Journal: Journal of Thoracic Oncology (2022)
EP16.03-027 Routine Molecular Testing Using the TSO500+ NGS Panel in a Cohort of Patients with NSCLC
Authors: M. Mosteiro Lamas, D. Azuara, R. Palmero, M. Varela, D. Cordero, N. Baixeras, S. Villatoro, A. Alay, L. Pijuán, M. Gausachs, J.C. Ruffinelli, M. Jové, N. Vilariño, A. Teulè, A. Solanes, C. Lázaro, X. Matías-Guiu, E. Nadal
Journal: Journal of Thoracic Oncology (2022)
EP08.01-018 Patterns of Failure in Metastatic NSCLC Treated with First Line Pembrolizumab and Impact of Local Therapy in Patients with Oligoprogression
Authors: C. Friedes, N. Yegya-Raman, C. Aggarwal, M. Marmarelis, R. Cohen, W. Levin, K. Cengel, C. Ciunci, J. Kosteva, A. Singh, K. Robinson, L. Sun, C. D'Avella, C. Davis, C. Langer, S. Feigenberg
Journal: Journal of Thoracic Oncology (2022)
EP08.02-027 T790M Detection Rate After First-Line Treatment with Bevacizumab Plus 1st or 2nd Generation EGFR-TKI in Advanced NSCLC
Authors: C.-H. Kuo, P.-L. Su, Y.-F. Wei, J.-C. Ko, J.-S. Tseng, J. Su, C.-L. Chiang, C.-Y. Chen, C.-C. Lin, C.-C. Wang, C.-C. HO, H.C. Chang, J.-Y. Hung
Journal: Journal of Thoracic Oncology (2022)
EP08.02-083 Real World Treatment and Outcomes in EGFR-mutated Advanced Non-small Cell Lung Cancer Patients: A Nationwide Cohort for 1,932 Thai Patients
Authors: K. Tienchai, S. Sa-nguansai, S. Payapwattanawong, P. Tienchaiananda, K. Maneenil
Journal: Journal of Thoracic Oncology (2022)
EP08.01-071 Safety and Efficacy of Sitravatinib + Tislelizumab in Patients with PD-L1+, Locally Advanced/Metastatic, Non-Squamous NSCLC
Authors: J. Zhao, J. Wu, J. Cui, L. Wang, M. Sun, B. Gao, Z. Ma, Y. Liu, Z. Wang, X. Li, H. Li, J. Zhang, J. Sun, C. Fei, Y.-L. Wu
Journal: Journal of Thoracic Oncology (2022)
EP10.01-004 Perspectives of Patients with Metastatic Lung Cancer on Symptom Screening and Patient-Reported Symptom Trajectory Data
Authors: A.H. Safavi, E. Bryson, V. Delibasic, F.C. Wright, A. Parmar, N. Coburn, A.V. Louie
Journal: Journal of Thoracic Oncology (2022)
EP16.03-034 Differential Prognostic Effect of EGFR Mutation According to Smoking Status and Pathologic Stage in Non-mucinous Lung Adenocarcinoma
Authors: J. Lee, S.H. Yoon, B. Shih, W. Jung, Y. Hwang, J.H. Jeon, S. Cho, K. Kim, S. Jheon
Journal: Journal of Thoracic Oncology (2022)
EP16.02-019 Metabolic Changes in Sputum and Exhaled Breath Condensate of Non-small Cell Lung Cancer Patients after Surgical Resection
Authors: N. Ahmed, B. Kidane, L. Wang, Z. Nugent, N. Moldovan, A. McElrea, S. Shariati-Ievari, G. Qing, L.T. Tan, G. Buduhan, S.K.S. Sadeesh K. Srinathan, R. Meyers, M.A. Aliani
Journal: Journal of Thoracic Oncology (2022)
EP08.05-001 Evaluation of Pneumonitis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Receiving Osimertinib and Thoracic Radiation
Authors: D.Y. Mak, M. Yan, P. Cheung, A. Parmar, I. Poon, Y. Ung, M. Tsao, A. Warner, A.V. Louie
Journal: Journal of Thoracic Oncology (2022)
EP08.02-045 Phase 1/2 Study of BLU-945 in Patients With Common Activating EGFR-Mutant Non-Small Cell Lung Cancer
Authors: E. Shum, Y. Elamin, Z. Piotrowska, D.R. Spigel, K.L. Reckamp, J. Rotow, D.S.W. Tan, S.M. Lim, T.M. Kim, C.-C. Lin, T. Kato, J. Parepally, F. Albayya, M. Louie-Gao, T. Weining, A. Zalutskaya, K. Goto
Journal: Journal of Thoracic Oncology (2022)
EP10.01-017 Use of Lalaby in Lung Cancer Patients to Trace Performance from Phone Sensors and Reported Outcomes Involving Quality of Life
Authors: T. Soria-Comes, S. Asensio–Cuesta, I. Maestu-Maiques, Á. Sánchez–García, M. Martín-Ureste, J.A. Conejero, J.M. García–Gómez
Journal: Journal of Thoracic Oncology (2022)
EP16.03-039 Characterizing SHPRH as a Novel Tumor Suppressor Gene in Lung Adenocarcinoma
Authors: T.S. Sihota, Y.T. Chen, A.L. Nagelberg, J.L.M. Chow, R. Shi, K. An, W.W. Lockwood
Journal: Journal of Thoracic Oncology (2022)
EP08.01-085 Sintilimab versus Pembrolizumab as Monotherapy or in Combination with Chemotherapy for Treatment Naïve Metastatic Non-small Cell Lung Cancer
Authors: S.-Y. Liu, Q. Zhou, H.-H. Yan, B. Gan, M.-Y. Yang, J.-Y. Deng, H.-Y. Tu, X.-C. Zhang, J. Su, J.-J. Yang, Y.-L. Wu
Journal: Journal of Thoracic Oncology (2022)
EP08.02-147 Clinical Outcomes in Patients with or without Cell Cycle Gene Alterations in EGFR mutated Non-Small Cell Lung Cancer
Authors: T. Chakrabarti, D.L. Kerr, F. Sun, R. Lea, L. Tan, W. Wu, B. Gini, T. Bivona, C.M. Blakely
Journal: Journal of Thoracic Oncology (2022)
EP16.03-028 Cancer Cells May be Re-sensitized to Tumor Treating Fields (TTFields) Through Inhibition of the PI3K/AKT/mTOR Pathway
Authors: A. Klein-Goldberg, T. Voloshin, E. Zemer-Tov, R. Paz, L. Koren, K. Wainer-Katsir, A. Volodin, B. Koltun, B. Brant, Y. Barsheshet, T. Kan, A. Haber, M. Giladi, U. Weinberg, Y. Palti
Journal: Journal of Thoracic Oncology (2022)
EP08.01-086 Pooled Mutant KRAS-Targeted Peptide Vaccine with Nivolumab and Ipilimumab in Advanced KRAS Mutated Non-Small Cell Lung Cancer
Authors: S. Rosner, N. Zaidi, H. Wang, K. Smith, J. Nauroth, M. Guo, P. Fitzpatrick, J. Riemer, A. Barnes, P. Wenga, J. Feliciano, C. Hann, V. Lam, J. Murray, S. Scott, V. Anagnostou, B. Levy, P. Forde, J. Brahmer, E. Jaffee, K. Marrone
Journal: Journal of Thoracic Oncology (2022)
EP08.01-097 Landscape and Dynamic Changes of Peripheral Immune Cells in Non-small Cell Lung Cancer Patients with First-line Immunotherapy
Authors: X. Chu, H. Sun, S. Chen, J. Zhao, J. Zhou, M. Xie, X. Yu, Y. Fang, X. Ji, J. Wu, J. Chen, Q. Wang, C. Su
Journal: Journal of Thoracic Oncology (2022)
EP08.02-016 Frontline and Post-Osimertinib Therapy for EGFR-mutant Advanced NSCLC: Treatment Patterns, Outcomes, Healthcare Use and Costs
Authors: N. Girard, B. Besse, R. Bernabé Caro, K. Goto, N. Leighl, Y. Ohe, J. Sabari, S-h. Lee, X. Lin, M. Schaeffer, S. Nair, T. Li, L. Di Scala, R. Potluri, P. Mahadevia, M. Thayu, T.M. Kim
Journal: Journal of Thoracic Oncology (2022)
EP16.04-009 The Proliferative Effect of 27-Hydroxycholesterol as a Selective Estrogen Receptor Modulator on Pathology of NSCLC
Authors: I. Takada, T. Miyazaki, H. Kanzawa, S. Shigefuku, H. Namikawa-Kanai, T. Matsubara, S. Ono, E. Nakajima, Y. Morishita, A. Honda, K. Furukawa, N. Ikeda
Journal: Journal of Thoracic Oncology (2022)
EP10.01-014 A Multidisciplinary Team to Manage Patients with Lung Cancer and Opioid Use Disorder
Authors: M. Huber, M. Pasquinelli, N. Gastala, J. Fleurimont, J. Jarrett, T. Hamlish, C. Sung, A. Guzman, P. Maes, K. Andersen, D. Manst, L. Feldman
Journal: Journal of Thoracic Oncology (2022)
EP08.01-021 Phase 2 Study Evaluating Inupadenant in Combination with Chemotherapy in Adults with NSCLC who Progressed on Immunotherapy
Authors: S. SRIVASTAVA, M. O’Brien, P.K. Cheema, C. Grohe, E. Carcereny, N. Girard, A.A. Chiappori, S. Ross, M. Rossetti, F. Dubois, J. Lager, V. Velcheti
Journal: Journal of Thoracic Oncology (2022)
EP16.01-015 Introducing "BiomeOne” a Microbiome-based bBiomarker to Predict Immune Checkpoint Inhibitor Response in NSCLC 1patients
Authors: M. Hochmair, G. Absenger, L. Ay, I. Robinson, C. Jansen, B. Sladek, A. Knabl, N. Gasche, A. Valipou
Journal: Journal of Thoracic Oncology (2022)
EP08.02-026 Real-world Efficacy of EGFR-TKI in Advanced NSCLC and Clinical Predictors of Outcome in Maharaj Nakorn Chiangmai Hospital in Thailand
Authors: C. Charoentum, K. Nasit, T. Ketpueak, T. Suksombooncharoen, B. Chewaskulyong
Journal: Journal of Thoracic Oncology (2022)
EP08.01-027 Durvalumab (D) ± Tremelimumab (T) + Chemotherapy (CT) in 1L Metastatic NSCLC: Outcomes by Tumour PD-L1 Expression in POSEIDON
Authors: E.B. Garon, B.C. Cho, A. Luft, J. Alatorre-Alexander, S.L. Geater, S.-W. Kim, G. Ursol, M. Hussein, F.L. Lim, C.-T. Yang, L.H. Araujo, H. Saito, N. Reinmuth, M. Kohlmann, X. Shi, H. Mann, S. Peters, T. Mok, M.L. Johnson
Journal: Journal of Thoracic Oncology (2022)
EP08.02-028 Germline HRR Mutations in Metastatic NSCLC and Impact on Progression-Free Survival: A Single-Center Retrospective Study
Authors: C. Vakkalagadda, L. Bucheit, Z. Sun, M. Kocherginsky, Y.K. Chae, Y. Boumber, N.A. Mohindra, J. Patel
Journal: Journal of Thoracic Oncology (2022)
EP16.03-036 Clinical and Genomic Features of HER2 exon 20 Insertion Mutations in East Asian NSCLC
Authors: S.P.L. Saw, A. Tan, J. Chen, G. Lai, N.O. Hlaing, A. Takano, D. Lau, J. Yeong, K.H. Lim, A. Skanderup, J. Chan, Y.L. Teh, T. Rajasekaran, A. Jain, W.L. Tan, Q.S. Ng, R. Kanesvaran, W.-T. Lim, E.H. Tan, M.-K. Ang, D.S.W. Tan
Journal: Journal of Thoracic Oncology (2022)
EP14.05-016 Patterns of Care for Small Cell Lung Cancer in Victoria Australia. A Prospective Population-Based Observational Study
Authors: J. Huang, W. Faisal, M. Brand, S. Smith, M. Alexander, M. Conron, M. Duffy, L. Briggs, J. Lesage, J. Philip, T. John, E. Samuel, M. MacManus, P. Mitchell, I. Olesen, P. Parente, C. Underhill, J. Zalcberg, S. Harden, R. Stirling
Journal: Journal of Thoracic Oncology (2022)
EP08.02-172 Effect of EGFR Inhibition on Bone Health in NSCLC Patients without Skeletal Metastasis
Authors: M. Mandruzzato, D.L. Cortinovis, E. Fassi, L. Ammoni, M. Zamparini, F. Colonese, S. Bianchi, A. Baggi, A. Berruti, S. Grisanti, M. Frigerio
Journal: Journal of Thoracic Oncology (2022)
EP08.02-122 Real-world Experience with Capmatinib in MET Exon 14-mutated Non-small Cell Lung Cancer (RECAP)
Authors: O. Illini, H. Fabikan, A. Swalduz, D. Krenbek, A. Vikström, M. Schumacher, E. Dudnik, M. Studnicka, R. Öhman, R. Wurm, L. Wannesson, N. Peled, W. Kian, J. Bar, S. Daher, A. Addeo, O. Rotem, G. Pall, A. Zer, A. Saad, T. Cufer, H.G. Sorotsky, S.M.S. Hashemi, K. Mohorcic, R. Stoff, Y. Rovitsky, S. Keren-Rosenberg, T. Winder, C. Weinlinger, A. Valipour, M.J. Hochmair
Journal: Journal of Thoracic Oncology (2022)
EP04.02-007 First Comprehensive Lung Cancer Long-Term Survivorship Program- Competing Risks
Authors: S. Nadjm, J.-P.H. Exner, R. Hepp De Los Rios, M. Metzenmacher, A.-C. Hoffmann, T. Gauler, C. Aigner, G. Stamatis, F. Oezkan, C. Schulte, K. Darwiche, C. Taube, D. Theegarten, T. Plönes, C. Pöttgen, L. Umutlu, H. Hautzel, M. Schuler, M. Stuschke, W.E.E. Eberhardt
Journal: Journal of Thoracic Oncology (2022)
EP07.03-007 Clinicopathological Analyses for Predicting Recurrence After Complete Resection of Thymoma
Authors: T. Suzuki, T. Hishida, K. Yano, T. Imoto, N. Oka, C. Maeda, Y. Okubo, K. Masai, K. Kaseda, K. Asakura, K. Emoto, H. Asamura
Journal: Journal of Thoracic Oncology (2022)
EP10.01-011 Prognostic Impact of Body Composition Phenotypes in Non-small Cell Lung Cancer Patients Receiving First-Line Pembrolizumab
Authors: I. Trestini, M. Cintoni, A. Caldart, A. Dodi, M. Sposito, D. Kadrija, L. Belluomini, J. Menis, E. Vita, I. Sperduti, A. Drudi, G. Aluffi, M. Todesco, D. Tregnago, A. Avancini, M. D'Onofrio, M.C. Mele, G. Tortora, M. Milella, E. Bria, S. Pilotto
Journal: Journal of Thoracic Oncology (2022)
EP16.03-030 AKT Inhibition as a Therapeutic Strategy to Constrain Histological Transdifferentiation in EGFR-mutant Lung Adenocarcinoma.
Authors: A. Quintanal-Villalonga, H. Taniguchi, Y.A. Zhan, N. Rekhtman, B. Houck-Loomis, R.P. Koche, H.A. Yu, T. Sen, C.M. Rudin
Journal: Journal of Thoracic Oncology (2022)
EP16.01-029 Inter-tumor Heterogeneity of PD-L1 Expression in Non-small Cell Lung Cancer
Authors: Y. Saito, S. Wakimoto, H. Morooka, T. Ibi, Y. Yamauchi, N. Takahashi, Y. Shimizu, T. Ikeya, Y. Sakao, M. Kawamura
Journal: Journal of Thoracic Oncology (2022)
EP08.02-041 NVL-520, a Highly Selective ROS1 Inhibitor, in Patients with Advanced ROS1-Positive Solid Tumors: The Phase 1/2 ARROS-1 Study
Authors: A. Drilon, S.-H.I. Ou, S. Gadgeel, M. Johnson, A. Spira, G. Lopes, B. Besse, E. Felip, A.J. van der Wekken, A. Calles, M.J. de Miguel, D.R. Camidge, Y. Elamin, S. Liu, J. Bauman, D. Haggstrom, G. Riley, H.E. Pelish, V.W. Zhu, J.J. Lin
Journal: Journal of Thoracic Oncology (2022)
EP08.02-171 PRO-CTCAE Analysis of Mobocertinib in EGFR Exon 20 Insertion‒Positive Metastatic Non‒Small Cell Lung Cancer (NSCLC)
Authors: M.R. García Campelo, C. Zhou, S.S. Ramalingam, H.M. Lin, T.M. Kim, G.J. Riely, T. Mekhail, D. Nguyen, J. Biber, H. Romero, E. Goodman, S. Popat, P.A. Jänne
Journal: Journal of Thoracic Oncology (2022)
EP16.02-021 The Expression of CEACAMs and Serum CEA Levels as Biomarkers of Postoperative Cancer Recurrence in Non-small Cell Lung Cancer
Authors: B. Na, O. Lee, Y.H. Kim, Y. Jung, K.J. Na, H.J. Lee, S. Park, I.K. Park, C.H. Kang, Y.T. Kim
Journal: Journal of Thoracic Oncology (2022)
EP13.01-001 The Burden of Incidental Extra-thoracic Positron Emission Tomography-CT (PET-CT) Findings in Thoracic Malignancies
Authors: D. Li, W. Parvez, M. Tiwari, M. Jones, M. Tufail, S. Agrawal, J. Bennett, R. Sudhir
Journal: Journal of Thoracic Oncology (2022)
EP11.02-002 A Comparative Study of PD-L1 Scoring: Humans versus AI
Authors: M. Plass, S. Dacic, I. Kern, M. Zacharias, H. Popper, J. Fukuoka, M. Kargl, H. Müller, C. Murauer, L. Brcic
Journal: Journal of Thoracic Oncology (2022)
EP08.02-079 The Use of Lung Adenocarcinoma Patient-Derived Xenografts and Organoids to Study GDP-KRAS G12C Inhibitor Resistance
Authors: J. Rosen, A. Sacher, N.-A. Pham, J. Weiss, Q. Li, T. Koga, S. Tucker, N. Radulovich, A. Koers, M. Niedbala, S. Ross, M.-S. Tsao
Journal: Journal of Thoracic Oncology (2022)
EP08.02-110 Plasma-based Molecular Profiling to Guide Treatment Decisions in Patients with Advanced NSCLC and Limited Tissue Biopsy
Authors: M. Arregui, M. Garcia, I. Martinez, I. Aparicio, V. Tirado, M. Galera, R. Alvarez, A. Calles
Journal: Journal of Thoracic Oncology (2022)
EP08.02-093 Loss of Tumor Endothelial QKI Expression Results in Pronounced Reductions in Metastasis and Remodeling of the Tumor Microenvironment
Authors: l. edatt, N. Sengottuvel, I.g. Allara, W.Y. Aw, W. Polacheck, A. Dudley, C.V. Pecot
Journal: Journal of Thoracic Oncology (2022)
EP08.02-088 Mutational Status of KRAS, STK11 and CDKN2A Genes as Predictors of Response to Antiangiogenic Agents in Non-small Cell Lung Cancer Patients
Authors: P. Cruz Castellanos, R. Rosas Alonso, I. Ozaez, I. Hernández, I. Losantos, L. Gutiérrez Sainz, O. Higuera Gómez, C. Rodríguez Antolín, I. Esteban Rodríguez, I. Ibáñez de Cáceres, J. De Castro Carpeño
Journal: Journal of Thoracic Oncology (2022)
EP08.02-084 Evaluation of Tumor Heterogeneity (TH) as a Prognostic Biomarker in Osimertinib treated Non-Small Cell Lung Cancer Patients
Authors: K. Murugesan, K.-K. Wong, K. Tolba, G. Oxnard, P. Hegde, G. Frampton, M. Montesion, D. Fabrizio
Journal: Journal of Thoracic Oncology (2022)
EP08.01-088 Direct Acting Antivirals (DAA) and Immune Checkpoint Inhibitors (ICIs) Therapy in Patients with Lung Cancer and Hepatitis C
Authors: M. Tagliamento, E. Cella, G. Sacco, G. Rossi, A. Limongelli, C. Dellepiane, G. Brucci, L. Zullo, F. Parisi, F. Baldi, E. Bennicelli, G. Barletta, S. Coco, S. Marconi, A. Alama, F. Bozzano, M.G. Dal Bello, C. Perrone, A. De Maria, C. Genova
Journal: Journal of Thoracic Oncology (2022)
EP08.01-048 Spanish Immunotherapy Registry of Cardiovascular Toxicity (SIR-CVT): Preliminary Analysis of the Lung Cancer Cohort
Authors: L. Gutiérrez Sainz, P. Cruz Castellanos, O. Higuera Gómez, T. López Fernández, B. Terol Espinosa de los Monteros, S. Valbuena López, A. Buño, E. Cuesta, E. Del Barco, E. Terán Brage, A. Martín García, R. Eiros Bachiller, C. Sánchez Pablo, N. Martínez Banaclocha, T. Lozano, I. Márquez Rodas, S. Pérez Ramírez, A. Calles Blanco, R. Álvarez, E. Zatarain Nicolás, J. De la Haba Rodríguez, P. Sánchez Mauriño, D. Mesa Rubio, F. Esteban Martínez, P. Martín Fernández, B. Ibáñez Cabeza, J. De Castro Carpeño
Journal: Journal of Thoracic Oncology (2022)
EP11.01-006 Setting Up an Ultra-Fast Next-Generation Sequencing Approach as a Reflex Testing at Diagnosis in Non-squamous Non-small Cell Lung Cancer
Authors: C. Bontoux, S. Heeke, V. Hofman, V. Lespinet-Fabre, O. Bordone, S. Lassalle, E. Long-Mira, S. Lalvée, V. Tanga, M. Allegra, M. Salah, J. Benzaquen, C.-H. Marquette, M. Ilié, P. Hofman
Journal: Journal of Thoracic Oncology (2022)
EP13.01-016 Are Follow-up Tests Useful in NSCLC? Experience of a Tertiary Hospital
Authors: F. Cano, Y. Garitaonaindía Díaz, V. Calvo, A. Collazo-Lorduy, M. Blanco Clemente, F. Franco, M. Martínez-Cutillas, C. Traseira, R. Aguado, G. Visedo, A. Gonzalez-Sanchez, D. Ruiz de Domingo, M.M. Sanchez del Corral, M. Provencio
Journal: Journal of Thoracic Oncology (2022)
EP08.02-173 Treatment Patterns and Outcomes Among Patients With EGFR-mutant Advanced NSCLC in the Frontline and Post-Osimertinib Settings
Authors: J. Sabari, S. Pisano, K. Gemmler, J. Mueller, R. Bernabé Caro, N. Girard, K. Goto, N. Leighl, Y. Ohe, T.M. Kim, S.-H. Lee, L. Demirdjian, R. Harvey, S. Rudolph, P. Mahadevia, J. Bauml, B. Besse
Journal: Journal of Thoracic Oncology (2022)
EP13.01-008 Needle Aspiration versus Forceps Biopsy Using Electromagnetic Navigation Bronchoscopy: CONFIDENT-ENB Trial Design
Authors: Y.W. Kim, H.-J. Kim, M.J. Song, B.S. Kwon, S.Y. Lim, Y.J. Lee, J.S. Park, Y.-J. Cho, J.H. Lee, C.-T. Lee
Journal: Journal of Thoracic Oncology (2022)